A synthetic IgG-binding domain based on staphylococcal protein A was designed with the aid of sequence comparisons and computer graphic analysis. A strategy, utilizing nonpalindromic restriction sites, was used to overcome the difficulties of introducing she-specific changes into the repetitive gene. A single mutagenized gene fragment was polymerized to different multiplicities, and the different gene products were expressed in Escherichia coli. Using this scheme, protein A-like proteins composed of different numbers of IgGbinding domains were produced. These domains were changed to lack asparagine-glycine dipeptide sequences as well as methionine residues and are thus, in contrast to native protein A, resistant to treatment with hydroxylamine and cyanogen bromide.
Introduction
Staphylococcal protein A (SPA) plays an important role in qualitative and quantitative immunology due to its specific binding to the Fc-portion of immunoglobulins from most mammalian species, including man (Langone, 1982) . In addition, a large number of biological properties have been attributed to SPA, e.g. Fab binding, activation of the complement system, hypersensitivity reactions, cell-mediated cytotoxicity, interferon induction, activation of polyclonal antibody synthesis and mitogenic stimulation of lymphocytes (Sjdquist and Stahlenheim, 1969; Cowan et al, 1979; Sjodahl and Moller, 1979; Romagnani et al., 1980; Inganas and Johansson, 1981; Catalona et al., 1981) . Because of its importance as an immunological tool and its diverse biological function, extensive structural and biochemical studies of SPA have been performed (Sjoquist et al., 1972; Hjelm et al., 1975; Sjodahl, 1977; Langone, 1982; Hanson and Schumaker, 1984) . However, despite these extensive studies, several conflicting models to explain both the structure and function of the IgG-SPA complex exist (Inganas and Johansson, 1981; Langone, 1982; Hanson and Schumaker, 1984) .
Recently, the gene encoding SPA was cloned (Lofdahl et al., 1983) , sequenced (UhMn et al., 1984a) and expressed in heterologous hosts (Uhlen et al., 1984b) . The sequence revealed a remarkably repetitive protein with two structurally and functionally different parts (Uhldn et al., 1984a) . The N-terminal part of the mature protein, responsible for the binding to the Fc-portion of IgG, consists of five homologous domains each of about 58 amino acid residues (Moks et al., 1986) which are individually IgG-binding (Sjodahl, 1977; Moks et al., 1986) . The C-terminal part is responsible for the association to the cell wall of © IRL Press Limited, Oxford, England Staphylococcus aureus (Guss et al., 1984) . Both ends of the primary sequence are hydrophobic corresponding to an Nterminal signal peptide (Abrahmsen et al., 1984) and a Cterminal transmembrane region (Uhlen et al., 1984c) .
Using protein engineering it is now possible to try to resolve some of the unanswered questions concerning the SPA-IgG interaction. Such studies may be realized since the complex between region B of protein A and the Fc-fragment of IgG have been crystallized and the three-dimensional structure has been resolved to a resolution of 2.8 A (Deisenhofer, 1981) .
However, the repetitive structure of the native SPA gene makes site-specific mutagenesis technically difficult. After mutations of one of the repeats the mismatch primer will, in the next mutagenesis step, anneal more efficiently to a mutated than to a non-mutated repeat. In addition, multiple region mutants are hard to select from a single region mutant by hybridization. These problems severely limit the value of protein engineering in the study of protein A.
In this paper, we introduce an alternative and general approach to mutagenize repetitive genes. Using obligate head-to-tail polymerization of a synthetic DNA fragment, mutated gene products consisting of different multiplicities of a protein A-like fragment were obtained. The system was used to construct IgG-binding molecules which are resistant to specific chemical treatments, without changing the function of the molecule. The use of this mutagenesis method to study the structure-function relationship of the SPA molecule is discussed.
Materials and methods

Bacterial strains and plasmids
Escherichia coli HB101 (Boyer and Roulland-Dussiox, 1969 ) and E. coli JM103 (Messing et al., 1981) were used as bacterial hosts. Plasmid and phage vectors were pRTT4 (Nilsson et al., 1985a) , pEMBL19, pEMBL8 (Dente et al., 1983) , M13mp8 (New England Biolabs) and phage fl (Dente et al., 1983) .
DNA techniques and cell growth
Restriction enzymes (Pharmacia, New England Biolabs and Boehringer Mannheim) were used according to the recommendations of the suppliers. Transformation and growth of E. coli were performed as described by Abrahmsen et al. (1986) . Singlestranded DNA from pEMBL-derived constructions for sequencing was prepared using fl as helper phage as described by Dente et al. (1983) .
DNA sequencing
The DNA sequencing was performed by the dideoxy method using reversed sequencing primer or the RTT-sequencing primer (Moks et al., 1986 ) (KabiGen AB, Sweden). Deoxynucleotides, dideoxynucleotides (Pharmacia, Sweden), [a-^SJdATP (Amersham International) and DNA polymerase large fragment (Boehringer Mannheim) were used. The labelled reaction mixtures were separated by electrophoresis on wedge shaped polyacrylamide gels (Olsson et al., 1984) using the thin gel Macrophor system (LKB, Sweden). 
Accl
The amino acids in the three possible reading frames are shown in a one letter code: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, He; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gin; R, Arg; S, Ser; T, Thr; V, Val; W, Tip; Y, Tyr: *, Stop. The numbers in the deduced amino acids columns are: 13 = AEGIKLPQRSTV*, 14 = AEGKLMPQRSTVW* and 15 = ACDFGHILNPRSTVY. There are also other restriction enzymes yielding asymmetric sticky ends, but recognizing 5 or 8 bp and therefore not included in the table, e.g. BgH, BstEQ, EcoKH, BstNl, Neil, Sau96l, Man and Sfil. DNA synthesis Synthesis of oligodeoxynucleotides was performed using an automated machine (KabiGen AB, Sweden) as described previously (Chow et al., 1981; Elmblad et al., 1982) . The deprotected oligomers were purified by PAGE.
DNA constructions
The derived DNA sequence for the synthetic gene fragment, designated Z, was divided into 10 oligodeoxynucleotides varying in length from 41 to 45 nucleotides and synthesized with overlaps of 6 bp. The oligonucleotides were phosphorylated separately using polynucleotide kinase (New England Biolabs). They were hybridized pair-wise, mixed and ligated to M13mp8 previously digested with EcoRUHimHR, transfected to E. coU JM103, followed by DNA sequencing. The M13mp8 containing the Z fragment was designated M13Z. The Z fragment was inserted in-frame after the promoter and signal sequence of the protein A gene by the use of the plasmid pHL3. The plasmid pHL3 was previously constructed by the insertion of the protein A gene contained on a TaqVEcoRl fragment from pRTT4 (Nilsson et al., 1985a) into ClaVEcoRl of the plasmid pEMBL19 (Dente et al., 1983) having the HindTH site filled in. The TaqVClal site was filled in and a synthetic Noil linker 5'-AGCGGCCGCT-3' (KabiGen AB, Sweden) was inserted. The plasmid pHL3 was cleaved with HindM (in the protein A gene) and £coRI. The Z fragment (Hindni/EcoRI) was isolated from M13Z and ligated to the cleaved pHL3. The resulting plasmid pHL3Z has the Z fragment out of frame but in the right orientation in the protein A gene. By cleaving pHL3Z with Fspl followed by re-ligation and transformation, the plasmid pASZ could be isolated in which the Z fragment is in-frame after the signal sequence and promoter of the protein A gene. This construction was transformed into E. coli JM103 and sequenced over the Z fragment and the junction to the signal sequence.
To obtain high expression of the Z fragment, the orientation of the protein A derived fragment was reversed in the pEMBL vector (Abrahmsdn et al., 1986) . A NotVBamYO. fragment of pASZ was ligated to NotVBamWl cleaved pEMBL8, having the Accl filled-in, and the £coRI linked to the Noil site. After transformation the plasmid vector pEZ could be isolated ( Figure  4 ). This vector encodes the signal sequence of staphylococcal protein A fused to the Z region but, in contrast to pASZ, the 108 Z gene is transcribed in the same direction as the transcription of the bla gene and as the direction of replication of the plasmid.
Protein purification
The Z-derived proteins were purified by IgG affinity chromatography using IgG Fast Flow Sepharose (Affinity Chromatography Workshop, Pharmacia Biotechnology, Uppsala, Sweden). The column was equilibrated with TST (50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween 20). After passage of the growth medium, the column was washed with 10 column volumes TST, 2 volumes TS (50 mM Tris pH 7.4, 150 mM NaCl) and 2 volumes 5 mM NH»Ac pH 5.5. Elution was performed by 1 M acetic acid titrated to pH 2.8 using NH«Ac. The eluted material was lyophilized prior to SDS-PAGE analysis.
Protein analysis
Protein A was quantitated by ELISA using Fab fragment of rabbit anti-protein A antibodies conjugated to /3-galactosidase (a kind gift from Dr M.Inganas, Pharmacia, Sweden) (Moks et al., 1986) . The analysis was performed by 8-25% gradient SDS-PAGE using the Phast system (Pharmacia, Sweden). The gel was stained with Coomassie Brilliant blue R-250 (LKB, Sweden).
Computer graphic analysis
The computer graphic analysis and simulations were performed using the program package FRODO (Jones, 1978 (Jones, , 1982 (Jones, , 1985 (Jones, , 1986 ) run on an Evans and Sutherland PS33O.
Results
Design of a synthetic igG-binding fragment
To facilitate mutagenesis of the IgG-binding part of SPA, we designed a synthetic monovalent IgG-binding domain, which could be polymerized at the DNA level in an obligate head-totail fashion using non-palindromic restriction sites. After sitedirected mutagenesis of the single region, polymerization to different multiplicities can be performed and the mutation will be distributed to all regions.
A comprehensive list of convenient non-palindromic sites, which can be used for DNA fragment polymerization, is shown in Table I . The deduced amino acid sequences of the three alternative reading frames spanning each restriction site are also shown. The table can be used to find a non-paUndromic site which may be introduced by site-directed mutagenesis to flank the gene fragment to be polymerized without altering the amino acid sequence, or to minimize the changes.
For the SPA molecule, the sequence at the junctions between all five IgG-binding domains is Ala-Pro-Lys-Ala-Asp (Uhle 'n et al, 1984a) , with the border defined at the C-terminal side of the trypsin sensitive lysine residue (Sjodahl, 1977; Moks et al., 1986) . Unfortunately, this sequence cannot be maintained with any of the sites listed in Table I . Two alternative strategies remain. The first is to introduce a non-palindromic site further into the sequence of the IgG-binding domain where an amino acid sequence, corresponding to a site in Table I can be found. The second is to allow an amino acid to be inserted, deleted or replaced to furnish a site. We decided to change an alanine residue in the junction into a valine residue. The substituted residue lies outside the a-helical regions involved in binding to IgG (Uhle'n et al, 1984b; Figure 1 ) and is thus unlikely to interfere with the binding. As a result of this amino acid replacement, the synthetic protein A region will contain a valine-aspartic acid dipeptide sequence, which can be encoded by a non palindromic Accl site (GTAGAC). By introducing the Accl site on both sides of the IgG-binding fragment a polymerization unit is formed.
In Figure 1 , a comparison of the five (E, D, A, B and Q homologous regions of the native SPA molecule and the synthetic IgG-binding domain, fragment Z, is shown. The design of the sequence of fragment Z will be described below. The two a-helices involved in the IgG-binding are boxed and the 11 residues that are proposed from structural data to interact with IgG (Deisenhofer, 1981) are underlined. Where amino acid differences occur between the synthetic and natural domains, these are shown as well as silent mutations (*). Figure 1 shows that regions A, B and C are highly homologous, with no amino acid differences within the two a-helices. Region D is slightly more diverged with three amino acid substitutions in the a-helical regions. Finally, region E is strikingly different, in particular within the N-terminal segment. The first eight residues have been substituted by six others compared to the other regions ( Figure  1 ). Despite these differences region E was recently shown to bind IgG (Moks et al., 1986) .
The methionine residues, present in the domains E, D and A (Figure 1 ), make protein A sensitive to cyanogen bromide treatment (Uhle'n and Nilsson, 1985) . In addition, the asparagine-glycine sequence present in all domains (E, D, A, B and Q makes the protein sensitive to hydroxylamine treatment (Uhle'n and Nilsson, 1985) . We decided to design a synthetic IgG-binding fragment lacking both the methionine residue and the asparagine-glycine sequence. These changes would facilitate the purification of peptides by gene fusions in which specific chemical cleavages are used to obtain the desired product (Uhle'n and Nilsson, 1985) . The synthetic fragment was based on the sequence of domain B, which lacks methionine residues ( Figure  1 ) and is thus cyanogen bromide resistant. There are however two more important reasons to choose this domain. First, domain B is closest to a hypothetical consensus sequence of the IgG-binding domains (Moks et al., 1986;  Figure 1) . Second, the structure of the protein A-IgG complex is based on crystallization studies using this domain (Deisenhofer, 1981) .
The proposed change in the asparagine-glycine dipeptide sequence at position 28-29 (Figure 1 ) is very critical since these residues are situated in one of the two a-helices responsible for the Fc-binding, the sequence being conserved in all five domains. As the domain B-IgG complex has been crystallized and the three dimensional structure solved (Deisenhofer, 1981), we decided to employ computer-aided graphics, using the program package FRODO (Jones, 1978 (Jones, , 1982 (Jones, , 1985 (Jones, , 1986 , to investigate the feasibility of changing the asparagine-glycine dipeptide se- (Boyer and RoullandDussiox, 1969 ) and on is the colEl origin of replication. S represents the signal sequence. The direction of transcription is shown by an arrow.
quence without interfering with IgG binding. Figure 2 shows the backbone of a-carbons of the protein A domain (green), the CH2 domain (red) and the CH3 domain (yellow). In addition, the sidechain of the asparagine residue in the unique asparagine-glycine dipeptide sequence is shown. As indicated in Figure 1 , this amino acid is involved in the interaction with IgG. As shown in Figure  2 , the protein A domain contains two antiparallel a-helices which are both involved in the binding to IgG at the site located between CH2 and CH3. The binding, with a dissociation constant of 2 X 10~8 M (Langone, 1982) , involves interactions between 11 residues of the protein A domain and 10 residues of the Fc molecule (Deisenhofer, 1981) . A more detailed view of this interaction can be seen in Figure  3 , in which all the side-chains of the residues in this area are shown. The asparagine side chain of SPA (Asn 28) forms a hydrogen bond to the side chain of a glutamine (Glu 311) in the Fc-fragment. This strongly suggests that substitution of this asparagine residue in domain B would be likely to affect the IgG interaction. In contrast, the neighbouring glycine residue (Gly 29), unusually placed in an a-helix, does not seem to be involved in the IgG interaction. With computer-graphic simulation, a methyl group was added to the glycine converting it into an alanine. This side chain substitution was found to be sterically acceptable to the structure (not shown). A comparison of the ahelix-forming properties of glycine and alanine suggests that the a-helix formation might even be enhanced. A mutation to an even larger side chain was not considered because we wished to make the minimum change in the structure. The computer-graphic analysis therefore suggests that the asparagine-glycine sequence in protein A may be changed to asparagine -alanine, to yield a hydroxylamine-resistant protein A-like domain.
The comparisons of domain Z to the five IgG-binding domains of native protein A reveals the following essential features ( Figure  1) . First, being based on fragment B it lacks methionine residues. Second, the glycine residue at position 29 has been substituted by an alanine to change the asparagine-glycine sequence. Finally, a non-palindromic Accl site has been introduced in the 5'-end of the the fragment to enable polymerization of the fragment. This site introduces a valine residue instead of an alanine residue in position 1. The Accl site is also present in the 3'-end of the synthesized Z fragment (not shown in Figure 1 ), thus encoding two additional amino acid residues. Synthesis and cloning of fragment Z Using overlapping synthetic oligonucleotides, fragment Z was assembled as described in Material and methods. We have earlier shown that the first six amino acids of domain E, which also are the N-terminal amino acids in mature protein A (Uhle"n et al., 1984a), differ from the other domains and are necessary for correct processing of the signal peptide (Abrahmse'n et al., 1984) . Therefore codons for these six amino acids were also synthesized and included upstream of the first Accl site of fragment Z. Plasmid pEZ was constructed containing the SPA promoter in front of the gene encoding the native SPA signal sequence followed by six residues of region E fused to the synthetic fragment Z (Figure 4 ) (for details see Materials and methods). The gene fusion terminates in a TAA stop codon downstream from the second Accl site, to yield a mature gene product Z with the predicted mol. wt of 9393.
The polymerization of the Z fragment was performed as described in Figure 4 . The plasmid pEZ was digested with Accl and both fragments (Z fragment and vector fragment) were isolated. The Z fragment was ligated for 15 min prior to the addition of vector fragment. The non-palindromic Accl ensures head-to-tail ligations due to the two non-identical sticky ends. Thus, the Z fragments will always be orientated in the transcription direction of the vector. After transformation to E. coli HB101, clones containing constructions with two or more Z fragments can be distinguished from those containing one or zero, as precipitation halos are formed around the colonies on agar plates containing 1 % canine serum. Although the structure of these precipitates is not known in detail (Inganas and Johansson, 1981) , the phenomenon is technically very useful. Restriction analysis indeed showed multiplicities of 2 -10 Z fragments of plasmid DNA isolated from different halo-forming clones. The multiplicities 2, 5 and 10 were selected for protein analysis and the plasmids were designated pEZZ, pEZV and pEZX respectively (Figure 4) . a 3 1 lab bench fermentor (Chemoferm, Sweden) using standard conditions (Abrahmse'n et al., 1986) . We have earlier found that protein A fragments expressed in E. coli from similar vectors were secreted to the growth medium of the host cells (Abrahmse'n et al., 1986) . Therefore, the culture medium was recovered by centrifugation and subsequently subjected to IgG affinity chromatography. After elution and lyophilization, the bound material was analyzed by SDS -PAGE ( Figure 5 ). The observed mol. wts are in good agreement with the values calculated from the deduced amino acid sequences of the mature proteins: 9393, 16 019, 35 887 and 69 000 daltons, respectively.
Expression of different multiplicities of fragment Z
Discussion
In this paper, we have demonstrated a strategy to perform protein engineering of the IgG-binding region of SPA. The system is based on a synthetic fragment Z, which was polymerized to different multiplicities using non-palindromic Accl sites. The asparagine-glycine dipeptide sequence and the methionine residue of SPA were removed to ensure resistance to hydroxylamine and cyanogen bromide respectively. The methionine was replaced simply by designing the new IgG-binding domain, Z, using the amino acid sequence of domain B (Figure 1 ). The asparagine-glycine dipeptide sequence was replaced by asparagine-alanine, based on results from computer-graphic analysis (Figures 2 and 3 ). In addition, an alanine residue outside the helical structures (residue 1 in Figure 1 ) was changed to a valine residue to furnish a non-palindromic Accl site. These amino acid replacements make it relevant to compare domains B and Z in terms of their relative affinity to IgG. Several observations support a binding of comparable or identical strength. First, precipitation halos around E. coli colonies can be used for qualitative measurements (Moks et al., 1986) . The halo produced by ZZ is identical in strength to the one produced by the gene product from regions EB but stronger than for do-112 mains EE (not shown), which has been suggested to have a lower affinity for IgG than EB (Moks et al., 1986) . Second, the binding strength between protein A fragments and IgG can be determined by the pH elution profile from IgG columns (Lindmark et al., 1983) . Domain Z and domain B are indeed eluted from IgG affinity columns at the same characteristic pH (not shown), which is slightly lower than the elution pH for domain E. IgG-binding competition studies using radioactively labelled domains B and Z are needed for a more exact comparison between the two domains.
The described concept for engineering of repetitive structures utilizes non-palindromic restriction sites, introduced at both ends of the DNA fragment encoding the repetitive unit to be engineered. After mutagenesis the fragment may be polymerized to any multiplicity by a ligation in which the non-palindromic site ensures a head-to-tail ligation (Harley and Gregori, 1981) . This method is suitable for engineering of any repetitive structure, such as collagen (Fuller and Boedtker, 1981) , streptococcal protein G (Guss et al., 1986) , streptococcal M protein (Hoolingshead, 1986) , Balbiani rings (Hoog and Wieslander, 1984) , pro-a-mating factor (Kurjan and Herskowitz, 1982) , transplantation antigens (Ohno et al., 1982) , fibronectin (Hirano et al., 1983) or rabbit skeletal tropomyosin (Fischetti and Manjula, 1982) . The method is limited by the need to find a nonpalindromic site to be introduced in the junction of two repeats without altering the amino acid sequence. To enable polymerization of the protein A gene fragment none of the restriction sites listed in Table I could be utilized without altering the amino acid sequence in the junction. An alanine residue was instead changed to a valine residue to furnish a non-palindromic Accl site (GTAGAC). Even though this change does not seem to interfere with the IgG binding, we cannot rule out effects on some of the other reported biological functions of protein A (Sjoquist and Stahlenheim, 1969; Cowan et al., 1979; Sjodahl and Moller, 1979; Romagnani et al., 1980; Inganas and Johansson, 1981; Catalona et al., 1981) .
The polymerization concept was used to polymerize Z fragments to multiplicities of 2, 5 and 10. These gene products were all expressed and secreted in E. coli hosts. The constructions containing five (pEZV) and 10 (pEZX) Z fragments were not stable in recA + strains. In addition, the pEZX construction was susceptible to homologous recombinations at low frequency even in the recA~ host (not shown). The question arises whether the high frequency of silent mutations found in the native protein A gene (Lofdahl et al., 1983;  Figure 1 ) reflects a selection pressure to avoid homologous recombinations of the five regions encoding the IgG-binding domains. Although homologous recombination is a well-known phenomenon in Gram positive bacteria (Michel et al., 1982) , the protein A gene does not seem to recombine in S. aureus. This is supported by an interesting finding by Guss et al. (1985) that an isolate of a S. aureus strain, expressing a truncated protein A containing only two functional IgG-binding domains, was not derived from recombination of the protein A gene, but instead results from a point mutation giving a stop codon.
We have earlier described the construction and use of fusion vectors based on the IgG-binding domains of staphylococcal protein A (Uhle 'n, 1983; Nilsson et al., 1985a,b) . The IgG-binding activity of the SPA 'affinity tail' allows for a rapid recovery of fusion products using IgG affinity chromatography. It is now possible to construct novel fusion vectors based on fragment Z. Such vectors will encode an improved IgG-binding protein with regard to resistance to hydroxylamine and cyanogen bromide treatments but having the same structure and function as the native molecule. These site-specific chemical cleavage methods may potentially be used for the purification of various peptides lacking methionine residues or asparagine-glycine dipeptides. A unique cleavage at the linker between the protein A moiety and the peptide would facilitate the recovery of the desired peptide simply by a second passage through the affinity column after cleavage, in which both uncleaved hybrid protein and intact 'affinity tail' will bind.
The Z fragment concept for the purification of peptides has recently been used to produce native human IGF-I (T.Moks, unpublished observations). Fusion protein (ZZ-IGF-I) was purified by IgG affinity chromatography, and subsequently cleaved by hydroxylamine followed by a second passage through the column. A pure native IGF-I with high specific biological activity was obtained by this procedure.
